Valuation — not yet established
No valuation for BirchBioMed is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($8.8M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for BirchBioMed
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Seed Round | $2.5M | ▮ | ▮ |
| Oct 2021 | Seed Round | $596K | ▮ | ▮ |
| Aug 2020 | Seed Round | $399K | ▮ | ▮ |
| Mar 2016 | Early Stage VC | $5.3M | ▮ | ▮ |
How BirchBioMed's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BirchBioMed, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has BirchBioMed raised?
- BirchBioMed has raised $8.8M in total funding across 4 recorded rounds.
- When did BirchBioMed last raise?
- BirchBioMed last raised in Jun 2025 (Seed Round), raising $2.5M.